A Qualitative Analysis of Patient-Related Factors Associated With Implantable Cardioverter Defibrillator Acceptance
- PMID: 32476091
- PMCID: PMC7584700
- DOI: 10.1007/s40119-020-00180-9
A Qualitative Analysis of Patient-Related Factors Associated With Implantable Cardioverter Defibrillator Acceptance
Abstract
Introduction: Patient-related factors determining implantable cardioverter-defibrillator (ICD) use for primary prevention of sudden cardiac death in patients with cardiomyopathy have not been well explored. To assess race and sex differences regarding ICD preferences in this patient population, we sought to analyze a diverse cohort of patients with heart failure (HF) with reduced ejection fraction.
Methods: We conducted qualitative interviews of 28 adults with severe HF and either (1) an ICD or (2) no ICD. Interviews were recorded, transcribed, and coded using an inductively developed codebook by independent investigators. Coding was fully adjudicated and transcripts were reviewed to identify themes.
Results: We recruited patients between 12/2015 and 06/2017, primarily from the outpatient cardiology clinic (24/28 = 86%). Half were women (50%) and 13/28 (46%) were black. Eight did not have an ICD. Neither race nor sex was associated with ICD. Four themes emerged: (1) HF requiring an ICD is profoundly disruptive to patients' lives; (2) patients had positive, yet unrealistic opinions of ICDs; or (3) Patients had negative/ambivalent opinions of ICDs; (4) medical decision-making included aspects of shared decision-making and informed consent.
Conclusions: Patients without ICDs perceived less benefit from ICDs and had less decision support. Participants viewed conversations with providers as insufficient. Needed interventions include the development and validation of processes for informed decisions about ICDs.
Keywords: Implantable cardioverter defibrillator; Practice guidelines; Shared decision-making.
Conflict of interest statement
Dr. Myaskovsky’s current affiliation is Department of Internal Medicine, University of New Mexico, School of Medicine, Albuquerque, NM, USA. Dr. Saba received research support from Boston Scientific and Abbott. Amber E. Johnson, Yamira K. Bell and Megan E. Hamm have nothing to disclose.
Figures
Similar articles
-
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1. Ont Health Technol Assess Ser. 2005. PMID: 23074465 Free PMC article.
-
Assisting Black Patients With Decision-Making for Implantable Cardioverter Defibrillator Therapy: Qualitative Findings From the Videos to Reduce Racial Disparities in ICD Therapy via Innovative Designs (VIVID) Trial.Circ Cardiovasc Qual Outcomes. 2024 Jul;17(7):e010550. doi: 10.1161/CIRCOUTCOMES.123.010550. Epub 2024 Jun 12. Circ Cardiovasc Qual Outcomes. 2024. PMID: 38864226 Clinical Trial.
-
Implantable cardiac defibrillators for people with non-ischaemic cardiomyopathy.Cochrane Database Syst Rev. 2018 Dec 8;12(12):CD012738. doi: 10.1002/14651858.CD012738.pub2. Cochrane Database Syst Rev. 2018. PMID: 30537022 Free PMC article.
-
Patients' Perspectives Regarding Generator Exchanges of Implantable Cardioverter Defibrillators.Circ Cardiovasc Qual Outcomes. 2023 Aug;16(8):509-518. doi: 10.1161/CIRCOUTCOMES.122.009827. Epub 2023 Jul 26. Circ Cardiovasc Qual Outcomes. 2023. PMID: 37492959 Free PMC article.
-
Decision-making regarding primary prevention implantable cardioverter-defibrillators among older adults.Clin Cardiol. 2020 Feb;43(2):187-195. doi: 10.1002/clc.23315. Epub 2019 Dec 23. Clin Cardiol. 2020. PMID: 31867773 Free PMC article. Review.
Cited by
-
The effect of virtual interactive nurse-led support group intervention on fatigue, shock anxiety, and acceptance of implantable cardioverter defibrillator patients: a randomized trial.BMC Cardiovasc Disord. 2024 Jan 11;24(1):40. doi: 10.1186/s12872-024-03713-5. BMC Cardiovasc Disord. 2024. PMID: 38212701 Free PMC article. Clinical Trial.
-
A qualitative crossroads of rhythm and race: Black patients' experiences living with atrial fibrillation.Am Heart J Plus. 2023 Apr;28:100293. doi: 10.1016/j.ahjo.2023.100293. Epub 2023 Mar 29. Am Heart J Plus. 2023. PMID: 37181157 Free PMC article.
-
Using Patient Decision Aids for Cardiology Care in Diverse Populations.Curr Cardiol Rep. 2023 Nov;25(11):1543-1553. doi: 10.1007/s11886-023-01953-z. Epub 2023 Nov 9. Curr Cardiol Rep. 2023. PMID: 37943426 Free PMC article. Review.
-
Impact of an Automated Best Practice Alert on Sex and Race Disparities in Implantable Cardioverter-Defibrillator Therapy.J Am Heart Assoc. 2022 Apr 5;11(7):e023669. doi: 10.1161/JAHA.121.023669. Epub 2022 Mar 18. J Am Heart Assoc. 2022. PMID: 35301858 Free PMC article. Clinical Trial.
-
[Between trivialization and pathologization: Healthcare in old age and the temporal structure of a good life].Ethik Med. 2023;35(1):77-91. doi: 10.1007/s00481-022-00742-6. Epub 2023 Jan 4. Ethik Med. 2023. PMID: 36619001 Free PMC article. German.
References
-
- Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335(26):1933–1940. doi: 10.1056/NEJM199612263352601. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous